4.3 Article

Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later

Related references

Note: Only part of the references are listed.
Article Neuroimaging

MRI correlates of disability progression in patients with CIS over 48 months

Tomas Uher et al.

NEUROIMAGE-CLINICAL (2014)

Article Clinical Neurology

Evolution of Cortical and Thalamus Atrophy and Disability Progression in Early Relapsing-Remitting MS during 5 Years

R. Zivadinov et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis

Robert Zivadinov et al.

RADIOLOGY (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

Cine cerebrospinal fluid imaging in multiple sclerosis

Christopher Magnano et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2012)

Article Clinical Neurology

Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria

Chris H. Polman et al.

ANNALS OF NEUROLOGY (2011)

Article Medicine, General & Internal

Inflammatory Cortical Demyelination in Early Multiple Sclerosis

Claudia F. Lucchinetti et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Multidisciplinary Sciences

Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models

Marzena J. Fabis et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Clinical Neurology

Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force

F. Deisenhammer et al.

EUROPEAN JOURNAL OF NEUROLOGY (2006)

Article Clinical Neurology

Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis

Sonja Hochmeister et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)

Article Clinical Neurology

Steroids and brain atrophy in multiple sclerosis

R Zivadinov

JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)

Article Clinical Neurology

Interferon-β stabilizes barrier characteristics of brain endothelial cells in vitro

J Kraus et al.

ANNALS OF NEUROLOGY (2004)

Article Radiology, Nuclear Medicine & Medical Imaging

Normalized accurate measurement of longitudinal brain change

SM Smith et al.

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2001)

Article Medicine, General & Internal

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.

LD Jacobs et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)